LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 6649 | 7934 | 0.8380 | 0.9467 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 6742 | 7934 | 0.8497 | 0.9509 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 7730 | 7934 | 0.9742 | 0.9920 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 7842 | 7934 | 0.9883 | 0.9964 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 706 | 7934 | 0.0890 | 0.3821 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 7556 | 7934 | 0.9523 | 0.9851 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 656 | 7934 | 0.0827 | 0.3666 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 62.29 | 84.90 | 8064 | 7934 | 1.0163 | 1.0050 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 6804 | 8212 | 0.8285 | 0.9438 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 6929 | 8212 | 0.8437 | 0.9491 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 7873 | 8212 | 0.9587 | 0.9872 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 8001 | 8212 | 0.9743 | 0.9921 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 901 | 8212 | 0.1097 | 0.4306 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 7966 | 8212 | 0.9700 | 0.9908 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 605 | 8212 | 0.0737 | 0.3468 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.99 | 84.90 | 8437 | 8212 | 1.0274 | 1.0082 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 7015 | 8484 | 0.8268 | 0.9436 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 7104 | 8484 | 0.8373 | 0.9473 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 7930 | 8484 | 0.9347 | 0.9798 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 8160 | 8484 | 0.9618 | 0.9883 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 839 | 8484 | 0.0989 | 0.4118 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 8304 | 8484 | 0.9788 | 0.9935 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 723 | 8484 | 0.0852 | 0.3805 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.70 | 84.90 | 8815 | 8484 | 1.0390 | 1.0115 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 7095 | 8766 | 0.8093 | 0.9378 | MN20160318_Q02 | D03 |